» Articles » PMID: 20813886

Standardizing Measurement of Chronic Obstructive Pulmonary Disease Exacerbations. Reliability and Validity of a Patient-reported Diary

Overview
Specialty Critical Care
Date 2010 Sep 4
PMID 20813886
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Although exacerbations are an important problem in chronic obstructive pulmonary disease (COPD) and a target of intervention, there is no valid, standardized tool for assessing their frequency, severity, and duration.

Objectives: This study tested the properties of the Exacerbations of Chronic Pulmonary Disease Tool (EXACT), a new patient-reported outcome diary.

Methods: A prospective, two-group, observational study was conducted in patients with COPD. The acute group (n = 222) was enrolled during a clinic visit for exacerbation with follow-up visits on Days 10, 29, and 60. The stable group (n = 188), recruited by telephone or during routine visits, was exacerbation free for at least 60 days.

Measurements And Main Results: Acute patients completed the diary on Days 1-29 and 60-67; stable patients for 7 days. All patients provided stable-state spirometry and completed the St. George Respiratory Questionnaire-COPD (SGRQ-C). Acute patient assessments included clinician and patient global ratings of exacerbation severity and recovery. Mean age of the sample (n = 410) was 65 (± 10) years; 48% were male; stable FEV₁ was 51% predicted (± 20). Internal consistency (Pearson separation index) for the EXACT was 0.92, 1-week reproducibility (stable patients; intraclass correlation) was 0.77. EXACT scores correlated with SGRQ-C (r = 0.64; P < 0.0001) and differentiated acute and stable patients (P < 0.0001). In acute patients, scores improved over time (P < 0.0001) and differentiated between degrees of clinician-rated exacerbation severity (P < 0.05). EXACT change scores differentiated responders and nonresponders on Day 10, as judged by clinicians or patients (P < 0.0001).

Conclusions: Results suggest the EXACT is reliable, valid, and sensitive to change with exacerbation recovery.

Citing Articles

Use of Ecological Momentary Assessment to Measure Dyspnea in COPD.

Miller S, Nichols M, Teufel Ii R, Silverman E, Walentynowicz M Int J Chron Obstruct Pulmon Dis. 2024; 19:841-849.

PMID: 38566847 PMC: 10985020. DOI: 10.2147/COPD.S447660.


Health Status Progression Measured Using Weekly Telemonitoring of COPD Assessment Test Scores Over 1 Year and Its Association With COPD Exacerbations.

Jones P, Soutome T, Matsuki T, Shinoda M, Hataji O, Miura M Chronic Obstr Pulm Dis. 2024; 11(2):144-154.

PMID: 38442134 PMC: 11075351. DOI: 10.15326/jcopdf.2023.0415.


The Conceptual Independence of Health Status, Respiratory Symptoms and Dyspnea in Chronic Obstructive Pulmonary Disease in Real Clinical Practice.

Nishimura K, Kusunose M, Mori M, Shibayama A, Nakayasu K Diagnostics (Basel). 2023; 13(15).

PMID: 37568855 PMC: 10417120. DOI: 10.3390/diagnostics13152492.


Multicentre double-blind randomised controlled trial of systematic corticosteroid therapy in patients with acute exacerbations of chronic obstructive pulmonary disease admitted to hospital with higher eosinophil levels: the ECHO protocol.

Liang L, Lin Y, Feng L, Shao S, Cao S, Rong H BMJ Open. 2023; 13(5):e066354.

PMID: 37247957 PMC: 10230870. DOI: 10.1136/bmjopen-2022-066354.


The BED-Pro Tool: facilitating the detection of bronchiectasis exacerbations.

Gao Y, Guan W ERJ Open Res. 2023; 9(3).

PMID: 37143843 PMC: 10152263. DOI: 10.1183/23120541.00087-2023.